A detailed history of Greenwood Capital Associates LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 12,233 shares of GMED stock, worth $863,894. This represents 0.11% of its overall portfolio holdings.

Number of Shares
12,233
Previous 12,065 1.39%
Holding current value
$863,894
Previous $647,000 29.37%
% of portfolio
0.11%
Previous 0.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$49.79 - $68.85 $8,364 - $11,566
168 Added 1.39%
12,233 $837,000
Q1 2024

May 01, 2024

BUY
$51.15 - $56.52 $195,546 - $216,075
3,823 Added 46.38%
12,065 $647,000
Q4 2023

Mar 05, 2024

SELL
$43.79 - $55.14 $6,787 - $8,546
-155 Reduced 1.85%
8,242 $439,000
Q3 2023

Oct 18, 2023

SELL
$49.1 - $62.37 $3,289 - $4,178
-67 Reduced 0.79%
8,397 $416,000
Q2 2023

Aug 07, 2023

SELL
$52.61 - $59.54 $10,364 - $11,729
-197 Reduced 2.27%
8,464 $503,000
Q1 2023

May 12, 2023

SELL
$51.83 - $79.63 $27,210 - $41,805
-525 Reduced 5.72%
8,661 $490,000
Q4 2022

Jan 26, 2023

SELL
$58.4 - $75.53 $52,735 - $68,203
-903 Reduced 8.95%
9,186 $0
Q3 2022

Nov 10, 2022

SELL
$55.32 - $67.54 $12,391 - $15,128
-224 Reduced 2.17%
10,089 $601,000
Q2 2022

Aug 10, 2022

BUY
$53.08 - $81.37 $33,121 - $50,774
624 Added 6.44%
10,313 $579,000
Q1 2022

May 10, 2022

BUY
$63.68 - $75.54 $15,474 - $18,356
243 Added 2.57%
9,689 $715,000
Q4 2021

Feb 03, 2022

BUY
$62.62 - $79.92 $16,907 - $21,578
270 Added 2.94%
9,446 $682,000
Q3 2021

Oct 27, 2021

SELL
$76.41 - $84.06 $4,661 - $5,127
-61 Reduced 0.66%
9,176 $703,000
Q2 2021

Aug 16, 2021

SELL
$61.85 - $77.53 $1,360 - $1,705
-22 Reduced 0.24%
9,237 $716,000
Q1 2021

May 14, 2021

SELL
$60.05 - $67.74 $10,748 - $12,125
-179 Reduced 1.9%
9,259 $571,000
Q4 2020

Feb 09, 2021

BUY
$48.89 - $65.87 $85,948 - $115,799
1,758 Added 22.89%
9,438 $616,000
Q3 2020

Nov 12, 2020

BUY
$45.26 - $57.82 $111,475 - $142,410
2,463 Added 47.21%
7,680 $380,000
Q2 2020

Aug 12, 2020

BUY
$39.81 - $55.61 $12,022 - $16,794
302 Added 6.14%
5,217 $249,000
Q1 2020

May 12, 2020

SELL
$35.06 - $59.45 $14,164 - $24,017
-404 Reduced 7.6%
4,915 $209,000
Q4 2019

Feb 12, 2020

BUY
$49.45 - $59.5 $65,076 - $78,302
1,316 Added 32.88%
5,319 $313,000
Q3 2019

Nov 12, 2019

BUY
$40.41 - $52.32 $161,761 - $209,436
4,003 New
4,003 $205,000
Q4 2018

Feb 11, 2019

SELL
$41.38 - $57.44 $151,285 - $210,000
-3,656 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$50.24 - $56.76 $183,677 - $207,514
3,656 New
3,656 $208,000
Q2 2018

Aug 07, 2018

SELL
$47.96 - $57.41 $225,459 - $269,884
-4,701 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$42.75 - $51.73 $10,730 - $12,984
-251 Reduced 5.07%
4,701 $234,000
Q4 2017

Feb 02, 2018

BUY
$28.86 - $41.64 $142,914 - $206,201
4,952
4,952 $204,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $5.44B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.